Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Luspatercept in Patients Affected With Rare Inherited Anemias

NCT07331818 is registered in ClinicalTrials.gov with EuroBloodNet Association as lead sponsor.

NCT NCT07331818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07331818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Luspatercept in Patients Affected With Rare Inherited Anemias
Lead sponsor
EuroBloodNet Association
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
September 30, 2029
Enrollment
45 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary red blood cell disorder (disorder)